Dow Up0.12% Nasdaq Up1.35%

Vertex Pharmaceuticals Incorporated (VRTX)

-NasdaqGS
104.77 2.42(2.36%) Oct 20, 4:00PM EDT
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):2.1
Mean Recommendation (last week):2.1
Change:0.0

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:115.41
Median Target:116.00
High Target:147.00
Low Target:80.00
No. of Brokers:22

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Jun 25, 2014H.C. WainwrightDowngradeBuyNeutral
Jan 6, 2014UBSUpgradeNeutralBuy
Oct 30, 2013Summer Street ResearchDowngradeBuyNeutral
Aug 22, 2013OppenheimerInitiated Outperform
Apr 19, 2013Canaccord GenuityUpgradeHoldBuy
Apr 10, 2013Chardan Capital MarketsInitiated Buy
Feb 7, 2013Robert W. BairdInitiated Outperform
Nov 28, 2012ArgusDowngradeBuyHold
Oct 4, 2012ArgusInitiated Buy
Jun 27, 2012Maxim GroupInitiated Buy

More Upgrades & Downgrades for VRTX

Data provided by Briefing.com - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy7666
Buy9877
Hold991010
Underperform0000
Sell0000

Data provided by Thomson/First Call


Currency in USD.